Search Results

Filter
  • 1-10 of  99,211 results for ""PROTEIN-tyrosine kinases""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Abdominal inflammatory myofibroblastic tumour: Clinicopathological and molecular analysis of 20 cases, highlighting potential therapeutic targets.

  • Authors : Vernemmen AIP; Department of Pathology, School for Oncology and Reproduction (GROW), Maastricht University Medical Center, Maastricht, The Netherlands.; Samarska IV

Subjects: Protein-Tyrosine Kinases*/Protein-Tyrosine Kinases*/Protein-Tyrosine Kinases*/genetics ; Sarcoma*/Sarcoma*/Sarcoma*/genetics; Humans

  • Source: Histopathology [Histopathology] 2024 Apr; Vol. 84 (5), pp. 794-809. Date of Electronic Publication: 2023 Dec 28.Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 7704136 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Report

Individualized targeted treatment in a case of a rare TFG::ROS1 fusion positive inflammatory myofibroblastic tumor (IMT).

  • Authors : Sommer S; Department of Hematology and Oncology, Faculty of Medicine, University of Augsburg, Augsburg, Germany.; Schmutz M

Subjects: Protein-Tyrosine Kinases*/Protein-Tyrosine Kinases*/Protein-Tyrosine Kinases*/genetics ; Neoplasms*; Female

  • Source: Cancer reports (Hoboken, N.J.) [Cancer Rep (Hoboken)] 2024 Jan; Vol. 7 (1), pp. e1916. Date of Electronic Publication: 2023 Nov 11.Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101747728 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Effect of High-Fat Food on the Pharmacokinetic Profile and Safety of SAF-189s, an ALK/ROS1 Inhibitor, in Healthy Chinese Adults.

  • Authors : Qin H; Department of Clinical Pharmacology, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China.; Tan Y

Subjects: East Asian People* ; Protein-Tyrosine Kinases*/Protein-Tyrosine Kinases*/Protein-Tyrosine Kinases*/pharmacokinetics ; Diet, High-Fat*

  • Source: Drugs in R&D [Drugs R D] 2023 Dec; Vol. 23 (4), pp. 465-473. Date of Electronic Publication: 2023 Nov 07.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100883647 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

ALK-Rearranged Epithelioid Mesenchymal Neoplasm: Expanding the Spectrum of Tyrosine Kinase-Altered Mesenchymal Tumors.

  • Authors : Gestrich CK; University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania; Boston Children's Hospital, Boston, Massachusetts.

Subjects: Protein-Tyrosine Kinases*/Protein-Tyrosine Kinases*/Protein-Tyrosine Kinases*/genetics ; Sarcoma*/Sarcoma*/Sarcoma*/genetics ; Sarcoma*/Sarcoma*/Sarcoma*/pathology

  • Source: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2023 Dec; Vol. 36 (12), pp. 100334. Date of Electronic Publication: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 8806605 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

[Receptor tyrosine kinase- fusions in paediatric spindle cell tumors].

  • Authors : Brenner C; Sektion Kinderpathologie, Institut für Pathologie, Universitätsklinikum Bonn, Venusberg-Campus 1, 53127, Bonn, Deutschland. .; Sanders C

Subjects: Protein-Tyrosine Kinases*/Protein-Tyrosine Kinases*/Protein-Tyrosine Kinases*/genetics ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/genetics; Humans

  • Source: Pathologie (Heidelberg, Germany) [Pathologie (Heidelb)] 2023 Nov; Vol. 44 (6), pp. 357-365. Date of Electronic Publication: 2023 Oct 11.Publisher: Springer Medizin Country of Publication: Germany NLM ID: 9918384887506676 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Molecular, clinicopathological characteristics and surgical results of resectable SMARCA4-deficient thoracic tumors.

  • Authors : Luo J; Department of Thoracic Surgery, School of Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, 241 West Huaihai Rd, Xuhui District, Shanghai, 200030, China.; Ding B

Subjects: Protein-Tyrosine Kinases* ; Thoracic Neoplasms*/Thoracic Neoplasms*/Thoracic Neoplasms*/genetics ; Thoracic Neoplasms*/Thoracic Neoplasms*/Thoracic Neoplasms*/surgery

  • Source: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2023 Jul; Vol. 149 (8), pp. 4455-4463. Date of Electronic Publication: 2022 Sep 19.Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection.

  • Authors : Capper D; Department of Neuropathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Subjects: Protein-Tyrosine Kinases* ; Glioma*/Glioma*/Glioma*/diagnosis ; Glioma*/Glioma*/Glioma*/genetics

  • Source: Neuro-oncology [Neuro Oncol] 2023 May 04; Vol. 25 (5), pp. 813-826.Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Domain Architecture of the Nonreceptor Tyrosine Kinase Ack1.

  • Authors : Kan Y; Department of Physiology and Biophysics, School of Medicine, Stony Brook University, Stony Brook, NY 11794-8661, USA.; Paung Y

Subjects: ErbB Receptors*/ErbB Receptors*/ErbB Receptors*/metabolism ; Protein-Tyrosine Kinases*/Protein-Tyrosine Kinases*/Protein-Tyrosine Kinases*/chemistry ; Protein-Tyrosine Kinases*/Protein-Tyrosine Kinases*/Protein-Tyrosine Kinases*/metabolism

  • Source: Cells [Cells] 2023 Mar 15; Vol. 12 (6). Date of Electronic Publication: 2023 Mar 15.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409

Record details

×
Academic Journal

ALK-positive lung cancer: a moving target.

  • Authors : Schneider JL; Massachusetts General Hospital Cancer Center and Department of Medicine, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.

Subjects: Receptor Protein-Tyrosine Kinases*/Receptor Protein-Tyrosine Kinases*/Receptor Protein-Tyrosine Kinases*/genetics ; Receptor Protein-Tyrosine Kinases*/Receptor Protein-Tyrosine Kinases*/Receptor Protein-Tyrosine Kinases*/therapeutic use ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/drug therapy

  • Source: Nature cancer [Nat Cancer] 2023 Mar; Vol. 4 (3), pp. 330-343. Date of Electronic Publication: 2023 Feb 16.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

In BTK, phosphorylated Y223 in the SH3 domain mirrors catalytic activity, but does not influence biological function.

  • Authors : Estupiñán HY; Department of Laboratory Medicine, Karolinska Institutet, Huddinge, Sweden.; Departamento de Ciencias Básicas, Universidad Industrial de Santander, Bucaramanga, Colombia.

Subjects: Protein-Tyrosine Kinases*/Protein-Tyrosine Kinases*/Protein-Tyrosine Kinases*/genetics ; Protein-Tyrosine Kinases*/Protein-Tyrosine Kinases*/Protein-Tyrosine Kinases*/metabolism ; src Homology Domains*

  • Source: Blood advances [Blood Adv] 2024 Apr 23; Vol. 8 (8), pp. 1981-1990.Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet

Record details

×
  • 1-10 of  99,211 results for ""PROTEIN-tyrosine kinases""